Insulins for the long term management of diabetes mellitus in dogs: a review.

Canine Med Genet. January 2022;9(0):1.

Robert E Shiel¹, Carmel T Mooney²

¹ School of Veterinary Medicine, University College Dublin, Belfield, Dublin 4, Ireland. robert.shiel@ucd.ie.; ² School of Veterinary Medicine, University College Dublin, Belfield, Dublin 4, Ireland.

Abstract

The year 2021 marked the centenary of the isolation of a therapeutic form of insulin and its successful use in dogs. This was a landmark moment that subsequently and rapidly led to the commercial manufacture of insulin for use in humans. The impact of insulin was almost miraculous as those destined to die from their diabetes mellitus returned to life. Over the past 100 years, insulin formulations have been modified to attempt to provide a predictable and prolonged duration of action while avoiding the development of hypoglycaemia. This has led to an ever-growing variety of insulin types in human medicine, many of which have subsequently been used in dogs. The purpose of this review article is to provide an overview of available insulin types and their application to the chronic management of canine diabetes mellitus.

Keywords

Diabetes mellitus; Dogs; Insulin; Pharmacology;

Article Tools:

Medline

Email to me

Comments:

Erratum In Canine Med Genet. 2022 Mar 4;9(1):3

Archives Highlights:

Neoplasms in Domestic Ruminants and Swine: A Systematic Literature Review.
In all species, the most frequent neoplasms were squamous cell carcinomas in ruminants, while melanoma was the most frequent in swine.

Risk factors for unilateral cranial cruciate ligament rupture diagnosis and for clinical management in dogs under primary veterinary care in the UK.
After accounting for confounding factors, dogs aged 6 to less than 9 years, male neutered and female neutered dogs, insured dogs, and Rottweiler, Bichon Frise, and West Highland White terrier breeds, in particular, had increased odds of unilateral CCL rupture diagnosis. Insured dogs and dogs = 20 kg had increased odds of surgical management, while dogs = 9 years and dogs with one non-orthopaedic comorbidity at diagnosis with CCL rupture had reduced odds. These findings inform identification of at-risk dogs.

Immunosuppressant Therapy in Small Animal Medicine: What, When, and Why
Immunosuppressant drugs are categorized into steroid medications (e.g., prednisone, prednisolone, dexamethasone, budesonide), calcineurin inhibitors (e.g., cyclosporine), antiproliferative medications (e.g., azathioprine, mycophenolate, leflunomide), and mechanistic target of rapamycin inhibitors (not currently used routinely in veterinary medicine). This article focuses on the first 3 categories.

A review of adverse events in animals and children after secondary exposure to transdermal hormone-containing medicinal products.
The clinical signs reported in animals included persistent signs of oestrus, poor growth rate, and birth defects. In humans, reported clinical signs included precocious puberty, unresolved virilisation, accelerated growth rate, and female infertility.

Understanding the Role of Therapy Dogs in Human Health Promotion.
Therapy dog programmes are delivered across a variety of settings including hospitals, aged care facilities and mental health services, highlighting the important role they play in human health outcomes. Research has shown that that there are biomarkers for stress in humans and other animals engaged in human-animal interactions. This review aims to assess the impact of human-animal interactions on therapy dogs engaged in providing support to human health.